Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies

Journal article

The anatomical differences between the retinas of humans and most animal models pose a challenge for testing novel therapies. Nonhuman primate (NHP) retina is anatomically closest to the human retina. However, there is a lack of relevant NHP models of retinal degeneration (RD) suitable for preclinical studies. To address this unmet need, we generated three distinct inducible cynomolgus macaque models of RD. We developed two genetically targeted strategies using optogenetics and CRISPR-Cas9 to ablate rods and mimic rod-cone dystrophy. In addition, we created an acute model by physical separation of the photoreceptors and retinal pigment epithelium using a polymer patch. Among the three models, the CRISPR-Cas9–based approach was the most advantageous model in view of recapitulating disease-specific features and its ease of implementation. The acute model, however, resulted in the fastest degeneration, making it the most relevant model for testing end-stage vision restoration therapies such as stem cell transplantation.

Authors: Ail, D; Nava, D; Hwang, IP; Brazhnikova, E; Nouvel-Jaillard, C

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: American Association for the Advancement of Science
• Journal: Science Advances
• Volume: 9
• Issue: 31
• Article number: eadg8163
• Publication date: 2023-08-04
• Acceptance date: 2023-06-29
• DOI: 10.1126/sciadv.adg8163
• EISSN: 2375-2548
• Language: English